|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | |
| A61K 31/573 | |||
| A61P 29/00 |
| (11) | Number of the document | 2773325 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12788306.4 |
| Date of filing the European patent application | 2012-11-02 | |
| (97) | Date of publication of the European application | 2014-09-10 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/NL2012/050766 |
| Date | 2012-11-02 |
| (87) | Number | WO 2013/066179 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| PCT/NL2011/0507 | 2011-11-04 | WO |
| (72) |
METSELAAR, Josbert Maarten, NL
|
| (73) |
Enceladus Pharmaceuticals B.V.,
St. Annastraat 38A, 1411 PH Naarden,
NL
|
| (54) | LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS IN HUMANS |
| LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS IN HUMANS |